Clinical Trial Update: Evaluation of Safety and Exploratory Efficacy of CARTISTEM®, a Cell Therapy Product for Articular Cartilage Defects [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update details the safety and exploratory efficacy results of CARTISTEM, an autologous cell therapy, for articular cartilage defects of the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Articular Cartilage Defects of the Knee

Drugs mentioned

• CARTISTEM

Snippet

Sponsor: Medipost, Inc. | Conditions: Degeneration Articular Cartilage Knee | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-07-30